coronavirus
cov
encod
mixtur
highli
conserv
novel
gene
well
genet
element
necessari
infect
pathogenesi
rais
possibl
common
target
attenu
therapeut
design
studi
focus
highli
conserv
nonstructur
protein
viral
encod
critic
function
immun
modul
infect
use
revers
genet
disrupt
key
motif
conserv
kdke
motif
middl
east
respiratori
syndrom
cov
merscov
evalu
effect
viral
infect
pathogenesi
absenc
activ
margin
impact
propag
replic
vero
cell
mutant
merscov
demonstr
signific
attenu
rel
control
primari
human
airway
cell
cultur
vivo
examin
indic
mutant
merscov
type
interferon
ifn
base
attenu
partial
restor
absenc
molecul
ifninduc
protein
tetratricopeptid
repeat
importantli
robust
attenu
permit
use
mutant
merscov
live
attenu
vaccin
platform
protect
challeng
mouseadapt
merscov
strain
studi
demonstr
import
conserv
activ
cov
pathogenesi
highlight
conserv
univers
target
rapid
live
attenu
vaccin
design
expand
cov
outbreak
set
import
coronaviru
cov
emerg
human
livestock
repres
signific
threat
global
public
health
evidenc
sudden
emerg
sever
acut
respiratori
syndrom
cov
sarscov
merscov
porcin
epidem
diarrhea
viru
swine
delta
cov
centuri
studi
describ
approach
effect
target
highli
conserv
activ
cov
attenu
clear
understand
ifnifit
ifninduc
protein
tetratricopeptid
repeat
base
mechan
mutant
provid
suitabl
target
live
attenu
vaccin
platform
well
therapeut
develop
current
futur
emerg
cov
strain
importantli
approach
target
conserv
pancov
function
yet
proven
effect
merscov
illustr
broad
applic
target
viral
function
across
cov
emerg
middl
east
respiratori
syndrom
coronaviru
merscov
repres
second
sever
cov
strike
human
popul
sinc
begin
centuri
similar
predecessor
sever
acut
respiratori
syndrom
cov
sarscov
merscov
character
sever
lung
infect
high
mortal
rate
associ
elderli
patient
nosocomi
spread
merscov
like
harbor
camel
popul
period
reintroduct
human
follow
period
nosocomi
outbreak
hospit
set
importantli
continu
rate
global
merscov
remain
ongo
threat
futur
outbreak
outsid
middl
east
evidenc
larg
outbreak
south
korea
togeth
factor
highlight
import
examin
cov
pathogenesi
develop
conserv
therapeut
target
treatment
current
futur
emerg
strain
like
member
cov
famili
merscov
maintain
balanc
conserv
novel
viral
protein
within
genom
member
group
cov
famili
wealth
distinct
accessori
open
read
frame
nonstructur
protein
nsp
alreadi
establish
import
role
modul
host
immun
respons
similarli
number
viral
protein
highli
conserv
structur
replic
fidel
also
maintain
cov
backbon
among
merscov
provid
potent
target
therapeut
develop
cov
implic
cap
viral
rna
prevent
recognit
intracellular
sensor
antivir
effector
includ
member
ifit
interferon
ifn
induc
protein
tetratricopeptid
repeat
famili
gener
mutant
chang
kdke
activ
site
result
ifnmedi
vitro
vivo
attenu
mous
hepat
viru
mhv
sarscov
therefor
approach
target
merscov
might
anticip
result
attenu
potenti
provid
univers
platform
cov
vaccin
futur
emerg
strain
use
revers
genet
target
residu
highli
conserv
activ
site
evalu
merscov
infect
outcom
context
inact
consist
previou
studi
sarscov
merscov
mutant
maintain
signific
attenu
term
replic
initi
host
immun
respons
howev
primari
human
airway
epitheli
hae
cell
vivo
studi
merscov
mous
model
demonstr
robust
attenu
mutant
growth
pathogenesi
notabl
attenu
ifn
depend
provid
clear
mechan
attenu
importantli
mutant
also
provid
robust
protect
lethal
merscov
challeng
maintain
attenu
mouseadapt
backbon
togeth
result
illustr
broad
conserv
necess
cov
pathogenesi
highlight
target
protein
rapidrespons
platform
futur
emerg
cov
strain
combin
structur
biochem
approach
establish
critic
role
cov
activ
fig
stabil
interact
orang
identifi
structur
conserv
adometdepend
methyltransferas
despit
diverg
protein
sequenc
across
organ
invari
kdke
motif
red
within
methyltransferas
core
requir
mediat
activ
kdke
motif
highli
conserv
within
sequenc
examin
cov
famili
fig
importantli
mutat
kdke
residu
shown
ablat
activ
addit
previou
alter
motif
group
sarscov
group
mhv
disrupt
activ
attenu
variou
aspect
infect
basi
high
conserv
cov
famili
hypothes
disrupt
kdke
motif
would
also
attenu
emerg
cov
famili
includ
group
merscov
util
merscov
revers
genet
system
disrupt
kdke
motif
mutat
two
nucleotid
produc
chang
fig
result
mutant
signific
defect
note
stock
titer
gener
shown
similarli
infect
vero
cell
cell
respiratori
epitheli
cell
line
low
multipl
infect
moi
demonstr
modest
attenu
late
time
point
fig
togeth
result
indic
activ
requir
replic
similar
vitro
host
respons
sarscov
merscov
mutant
establish
replic
compet
vero
cell
next
evalu
induct
host
pathway
follow
infect
cell
infect
moi
demonstr
differ
replic
shown
modest
differ
host
induct
zero
gene
log
chang
express
similar
observ
mutant
sarscov
compar
wildtyp
wt
sarscov
howev
unlik
studi
sarscov
rapid
cytopath
effect
cpe
h
limit
analysi
earli
time
point
wt
mutant
shown
gray
highlight
conserv
kdke
motif
red
requir
activ
also
shown
scaffold
requir
merscov
orang
inset
display
conserv
kdke
left
mutat
right
disrupt
function
homolog
model
creat
model
maxplanck
institut
bioinformat
toolkit
known
crystal
structur
complex
rcsb
protein
data
bank
use
templat
structur
homolog
model
manipul
macpymol
b
heat
map
construct
set
repres
cov
four
genogroup
use
align
data
pair
neighborjoin
phylogenet
tree
built
geneiou
visual
evolview
davidbas
analysi
compar
network
host
respons
merscov
sarscov
mutant
fig
first
h
infect
merscov
sarscov
mutant
infect
show
signific
function
enrich
categori
rel
correspond
wt
infect
consist
lack
replic
attenu
howev
late
time
h
postinfect
sarscov
produc
robust
chang
sever
host
pathway
includ
cytokin
respons
inflamm
extracellular
activ
similarli
chang
apoptosi
transcript
repress
regul
phosphoryl
indic
host
respons
hostil
viral
infect
rapid
cpe
follow
wt
mutant
merscov
infect
preclud
equival
find
late
time
point
sarscov
result
suggest
absenc
activ
eventu
initi
host
respons
chang
contribut
attenu
late
time
point
merscov
mutant
attenu
primari
vivo
model
examin
replic
capac
mutant
infect
hae
cell
mice
express
human
dipeptidyl
peptidas
receptor
merscov
primari
hae
cell
cultur
challeng
wt
merscov
low
moi
fig
robust
replic
observ
follow
wt
infect
merscov
signific
attenu
correspond
well
previou
result
obtain
mutant
sarscov
next
examin
mutant
merscov
replic
phenotyp
context
vivo
infect
use
adenoviru
balbc
mous
transduct
model
neither
infect
produc
weight
loss
shown
wt
merscov
replic
effici
day
postinfect
fig
contrast
detect
replic
seen
follow
infect
mutant
merscov
lack
replic
may
due
residu
ifn
respons
associ
initi
adenoviru
infect
greater
clariti
next
infect
mice
includ
mutat
posit
confer
effici
wt
merscov
infect
growth
mice
clinic
diseas
follow
infect
chang
observ
weight
loss
either
group
mice
consist
previou
find
data
shown
howev
absenc
activ
sever
attenu
mutant
viru
replic
day
postinfect
fig
coupl
data
hae
cell
cultur
adenoviru
model
result
demonstr
clear
attenu
mutant
merscov
rel
control
mutant
merscov
attenu
mediat
ifn
establish
deficit
mutant
merscov
replic
relev
vitro
vivo
model
next
sought
evalu
mechan
attenu
previou
work
lab
other
establish
increas
suscept
mutant
type
ifn
howev
mutant
sarscov
shown
augment
type
ifn
stimul
follow
infect
consist
find
infect
mutant
merscov
produc
stimul
type
ifn
transcript
similar
seen
follow
vivo
infect
mutant
crispr
mice
wt
viru
fig
contrast
wt
mutant
virus
sensit
ifn
treatment
mutant
merscov
signific
reduct
replic
rel
control
viru
fig
attenu
result
consist
report
mutant
cov
contrast
equival
replic
observ
without
pretreat
fig
extend
analysi
examin
role
gene
express
attenu
phenotyp
previous
con
struct
stabl
short
hairpin
rna
shrna
knockdown
cell
line
similar
sarscov
knockdown
augment
replic
mutant
merscov
context
type
ifn
pretreat
fig
addit
knockdown
augment
wt
merscov
infect
suggest
sensit
activ
despit
presenc
notabl
knockdown
modest
nonsignific
impact
replic
contrast
result
obtain
sarscov
overal
data
indic
mutant
merscov
attenu
driven
sensit
type
ifn
mediat
activ
rather
augment
ifn
respons
mutant
vaccin
protect
lethal
merscov
challeng
basi
ifn
attenu
phenotyp
target
offer
potenti
platform
strategi
live
attenu
vaccin
gener
previou
work
group
shown
mutant
sarscov
confer
protect
lethal
challeng
similar
phenotyp
distant
cov
essenti
establish
univers
principl
attenu
across
viru
famili
test
hypothesi
mutant
mice
vaccin
mutant
merscov
subsequ
challeng
mouseadapt
merscov
strain
fig
follow
challeng
mutantvaccin
mice
show
modest
weight
loss
signific
contrast
sever
diseas
seen
control
group
fig
addit
viral
replic
lung
hemorrhag
significantli
reduc
context
mutant
vaccin
fig
c
importantli
serum
analysi
reveal
robust
viru
neutral
valu
similar
seen
serum
wt
virusinfect
mice
fig
togeth
result
indic
mutant
merscov
function
vaccin
platform
induc
high
level
neutral
antibodi
provid
compet
protect
lethal
merscov
challeng
mutat
attenu
mouseadapt
merscov
despit
confer
protect
wt
merscov
backbon
unclear
mutant
would
suffici
attenu
virul
merscov
backbon
address
question
insert
mutat
mouseadapt
merscov
backbon
follow
infect
mouseadapt
merscov
produc
rapid
weight
loss
death
fig
contrast
mouseadapt
mutant
produc
modest
weight
loss
surviv
follow
infect
addit
replic
mutant
significantli
attenu
rel
wt
day
postinfect
fig
final
hemorrhag
score
lung
reveal
minim
diseas
mutantimmun
mice
rel
control
mice
day
postinfect
fig
overal
result
demonstr
robust
attenu
merscov
pathogenesi
context
mutat
context
ongo
merscov
outbreak
develop
univers
platform
strategi
attenu
emerg
contemporari
cov
signific
prioriti
studi
demonstr
critic
import
function
merscov
pathogenesi
vitro
vivo
similar
mhv
sarscov
disrupt
activ
merscov
signific
impact
replic
earli
host
respons
pattern
vitro
howev
mutant
merscov
demonstr
attenu
replic
growth
primari
hae
cell
cultur
well
reduc
diseas
vivo
rel
wt
viru
examin
reveal
increas
sensit
type
ifn
ifitdepend
manner
notabl
ifnifitbas
attenu
phenotyp
provid
robust
protect
lethal
challeng
follow
vaccin
mutant
importantli
mutant
also
fulli
attenu
highli
virul
mouseadapt
merscov
backbon
result
coupl
previou
work
cov
highlight
viral
activ
potenti
univers
platform
therapeut
treatment
vaccin
develop
current
futur
emerg
human
anim
cov
similar
previous
viral
methyltransferas
mutant
flavivirus
cov
substitut
highli
conserv
kdke
motif
alter
pathogen
merscov
like
sarscov
mutant
mutant
merscov
normal
replic
attenu
context
type
ifn
ifit
activ
notabl
absenc
activ
result
increas
type
ifn
respons
suggest
loss
produc
sensit
ifit
activ
seen
wt
viru
mutant
rna
induc
greater
ifn
activ
multipl
cov
protein
shown
disrupt
immun
recognit
similarli
viral
process
includ
replic
within
doubl
membran
vesicl
may
also
limit
ifn
stimul
togeth
result
indic
even
without
cov
abl
control
ifn
stimul
replic
effici
wt
viru
howev
need
protect
virus
ifnstimul
gene
isg
effector
respons
initi
attenu
merscov
mutant
also
provid
evid
support
target
viral
global
therapeut
strategi
emerg
rna
virus
previou
work
flavivirus
cov
demonstr
robust
attenu
target
conserv
kdke
motif
viral
mtase
importantli
activ
known
function
appear
complet
dispens
cov
replic
absenc
strong
ifn
respons
contrast
flavivirus
without
methyltransferas
activ
much
sensit
innat
immun
respons
mutant
west
nile
viru
dengu
viru
japanes
enceph
viru
highli
replic
attenu
earli
time
point
diminish
viru
yield
like
reduc
flaviviru
vaccin
util
vivo
robust
propag
merscov
sarscov
mutant
provid
use
paramet
vaccin
gener
viral
famili
drug
target
activ
may
great
efficaci
pair
stimul
ifnrespons
gene
includ
overal
result
indic
viral
activ
critic
determin
pathogenesi
leverag
develop
therapeut
treatment
also
repres
third
highli
conserv
cov
protein
target
basi
vaccin
platform
previou
work
group
demonstr
import
cov
fidel
infect
pathogenesi
disrupt
exonucleas
activ
render
attenu
reversionproof
version
mhv
sarscov
sarscov
disrupt
serv
basi
success
live
attenu
vaccin
similarli
group
target
envelop
protein
sarscov
defin
key
inflammatori
role
e
protein
pathogenesi
sar
mutant
target
e
function
also
confer
protect
lethal
challeng
e
mutant
fidel
inflamm
induct
partial
respons
attenu
howev
viral
mutant
also
maintain
replic
attenu
term
kinet
yield
potenti
complic
use
vaccin
platform
especi
outbr
popul
importantli
mutant
yet
recov
within
context
merscov
failur
report
group
cov
similarli
disrupt
e
protein
render
merscov
transmiss
gastroenter
viru
mhv
replic
defici
without
exogen
complement
broad
attenu
delta
e
mutant
potenti
limit
use
live
attenu
vaccin
contrast
mutant
merscov
maintain
robust
propag
well
ifnifitbas
attenu
phenotyp
togeth
result
suggest
target
may
broadli
applic
platform
cov
attenu
despit
success
mutant
protect
studi
sarscov
merscov
sever
addit
paramet
must
consid
context
cov
vaccin
previou
work
group
demonstr
failur
cov
subunit
vaccin
age
anim
context
heterolog
challeng
age
repres
popul
high
mortal
rate
margin
vaccin
success
efficaci
mutant
popul
paramount
pursuit
platform
similarli
exist
numer
cov
anim
popul
rais
concern
heterolog
challeng
emerg
virus
prior
report
also
demonstr
vaccineinduc
diseas
follow
heterolog
challeng
relat
sarslik
virus
mind
mice
need
examin
context
heterolog
challeng
determin
vaccineinduc
patholog
occur
togeth
two
factor
repres
import
checkpoint
pursuit
univers
cov
vaccin
platform
addit
age
heterolog
challeng
revers
baselin
pathogenesi
also
repres
import
risk
must
evalu
context
vaccin
sar
vaccin
absent
steril
immun
immunodefici
mice
lack
revers
time
vivo
indic
safeti
approach
contrast
passag
e
mutant
render
novel
mutant
transplant
critic
ion
channel
function
anoth
viral
protein
thu
restor
partial
virul
studi
examin
revers
potenti
critic
prior
use
vaccin
concern
especi
import
consid
sarscov
merscov
mutant
robust
replic
permit
addit
opportun
revers
addit
equival
host
immun
respons
earli
infect
may
produc
substanti
damag
prior
ifnifitbas
attenu
notabl
age
immunocompromis
mice
therefor
despit
promis
success
attenu
multipl
cov
backbon
sever
addit
metric
must
examin
prior
use
mutant
univers
cov
vaccin
platform
overal
present
studi
demonstr
target
activ
robust
strategi
attenu
merscov
emerg
cov
absenc
activ
merscov
mutant
sensit
type
ifn
ifitdepend
manner
provid
clear
attenu
mechan
importantli
unlik
conserv
cov
platform
mutant
viabl
robust
enough
use
effect
live
attenu
vaccin
vaccin
character
requir
result
indic
disrupt
cov
activ
basi
therapeut
strategi
current
futur
emerg
cov
infect
human
anim
popul
cell
virus
wt
mutant
mouseadapt
version
merscov
use
studi
previous
describ
cultur
vero
cell
grown
dulbecco
modifi
eagl
medium
optimem
gibco
carlsbad
ca
fetal
bovin
serum
hyclon
south
logan
ut
along
antibioticantimycot
gibco
carlsbad
ca
growth
curv
vero
hae
cell
perform
previous
describ
examin
multipl
sampl
n
time
point
briefli
cell
wash
phosphatebuff
salin
pb
inocul
viru
mock
dilut
pb
min
follow
inocul
cell
wash
three
time
fresh
medium
ad
signifi
time
zero
sampl
harvest
time
point
describ
ifn
pretreat
uml
recombin
human
pbl
laboratori
ad
cell
h
prior
inocul
cell
infect
describ
stabl
shrna
knockdown
vero
cell
line
previous
describ
previou
cov
studi
phenotyp
valid
viru
cultiv
perform
biosafeti
level
laboratori
redund
fan
biosafeti
cabinet
describ
previous
group
personnel
wore
powder
air
purifi
respir
breath
easi
tyvek
suit
apron
booti
doubl
glove
construct
wt
mutant
virus
wt
mutant
virus
deriv
either
merscov
emc
correspond
mouseadapt
infecti
clone
previous
describ
mutant
construct
mutat
chang
sequenc
merscov
e
fragment
clone
psmart
vector
lucigen
use
alanin
scan
mutagenesi
conserv
residu
chang
product
gener
pcr
primer
merscov
fragment
emc
e
tgaactacctgtagctgtag
emc
emuc
nnnnnngctcttctcgcggaaataacaagatccacttg
fragment
emc
emuc
nnnnnngctcttc
cgcgatgtatgatcctactactaag
emc
e
caacctcaatacaagcagac
two
result
product
digest
sapi
boldfac
ligat
overnight
dna
ligas
product
digest
ppumi
nsii
use
replac
region
emc
e
plasmid
similarli
digest
thereaft
plasmid
contain
wt
mutant
merscov
genom
fragment
amplifi
excis
ligat
purifi
vitro
transcript
reaction
perform
synthes
fulllength
genom
rna
transfect
vero
cell
medium
transfect
cell
harvest
use
seed
stock
subsequ
experi
viral
mutant
confirm
sequenc
analysi
prior
use
synthet
construct
mutant
approv
univers
north
carolina
institut
biosafeti
committe
rna
isol
microarray
process
identif
de
rna
isol
microarray
process
qualiti
control
normal
cell
carri
previous
describ
differenti
express
de
determin
compar
virusinfect
replic
timematch
mocktreat
replic
criteria
de
determin
consensu
isg
list
absolut
log
chang
falsediscoveri
rateadjust
p
valu
given
time
point
cluster
function
enrich
gene
identifi
differenti
express
use
gener
cluster
express
heat
map
hierarch
cluster
use
euclidean
distanc
complet
linkag
cluster
use
cluster
gene
express
accord
behavior
across
experiment
condit
david
onlin
resourc
http
davidncifcrfgov
use
acquir
function
enrich
result
gene
cluster
david
output
manual
summar
cluster
plot
gener
r
ethic
statement
studi
carri
accord
recommend
care
use
laboratori
anim
offic
laboratori
anim
welfar
olaw
nation
institut
health
institut
anim
care
use
committe
iacuc
univers
north
carolina
chapel
hill
unc
permit
approv
anim
studi
protocol
use
studi
iacuc
protocol
mous
infect
vaccin
tento
balbc
envigoharlan
mice
anesthet
ketamin
xylazin
accord
unc
iacuc
guidelin
intranas
inocul
volum
contain
pfu
wt
merscov
mutant
merscov
mouseadapt
variant
pb
mock
inocul
indic
figur
legend
infect
anim
monitor
weight
loss
morbid
clinic
sign
diseas
lung
viru
titer
determin
describ
previous
vivo
adenoviru
transduct
perform
previous
describ
vaccin
experi
mice
infect
pfu
mutant
merscov
describ
monitor
clinic
symptom
day
challeng
week
postvaccin
pfu
mousepassag
merscov
anim
hous
care
experiment
protocol
accord
unc
iacuc
guidelin
data
avail
raw
microarray
data
studi
deposit
publicli
avail
databas
nation
center
biotechnolog
inform
ncbi
gene
express
omnibu
access
geo
seri
